Searchable abstracts of presentations at key conferences in endocrinology

ea0021p56 | Clinical practice/governance and case reports | SFEBES2009

Investigating for Cushing's syndrome in a patient with increased BMI on rifampicin

Ali Mansoor , Andrew Julie , Mbagaya Wycliffe , Orme Steve

A 39-year-old rugby league player was admitted with back pain to an Endocrinology/General Medicine ward. He was diagnosed with osteomyelitis of the spine and was treated with antibiotic. During his prolonged in-patient stay (6 weeks i.v. antibiotic treatment), the presence of purple striae on his lower abdomen was noted. Although he did not have other classical features of a Cushing’s syndrome including proximal myopathy, he had an increased BMI (38 kg/m2) and ...

ea0021p64 | Clinical practice/governance and case reports | SFEBES2009

A man with short stature and absent testis

Singh Prashant , Pickett Pat , Rooproy Adwin , Moulik Probal , Macleod Andrew

A 63-year-old phenotypic male presented with absent testis and enlarged adrenal glands. He had attended the urology clinic for persistent microscopic haematuria. He was found to have an empty scrotum and hypospadias. The patient recalled having genital surgery in childhood but could not recall any endocrine assessment. He was taller than his peers in early childhood but stopped growing after age 13 years. He described himself as ‘potent’. He was unmarried and did not...

ea0021p114 | Clinical practice/governance and case reports | SFEBES2009

The endocrine consequences of stem cell transplantation

Kennedy Amy , Nunnick Jane , Clark Fiona , Craddock Charles , Toogood Andrew

Over the last 10 years there have been significant advances in stem cell transplantation (SCT) in adults for haematological malignancies leading to improved survival. Conditioning regimes prior to transplantation often utilise high dose chemotherapy and/or total body irradiation (TBI). Significant endocrinopathies have been reported amongst children undergoing SCT. We report the effect of SCT during adult life on endocrine function.Basal hormone levels w...

ea0021p121 | Cytokines and growth factors | SFEBES2009

Peripheral blood mononuclear cells from active rheumatoid arthritis patients show a defective induction of adrenomedullin

Green Laura , Berry Andrew , Donn Rachelle , Ray David

Rheumatoid arthritis (RA) is a common chronic systemic inflammatory disease. Several new therapies exist for RA but long-term patient management remains problematic.We have discovered that hypoxia, a characteristic of inflamed tissues, potently inhibits glucocorticoid (Gc) sensitivity. This effect is mediated, in part by HIF1α, whose activity is induced in hypoxia. HIF1α gene expression is also induced in primary peripheral blood mononuclear ce...

ea0021p171 | Diabetes and metabolism | SFEBES2009

Biomarkers of the hypothalamic-pituitary-adrenal (HPA) axis for analysis of in vivo 11β-hydroxysteroid dehydrogenase 1 inhibition

Harno Erika , Yu Alice , Leighton Brendan , Turnbull Andrew , White Anne

Inhibition of 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) as a means of reducing tissue corticosteroids is showing marked potential as a treatment for type 2 diabetes. However, reduction in tissue corticosteroids may lead to upregulation of the HPA axis. Therefore this study investigates the effect of 11β-HSD1 inhibition on HPA axis biomarkers and examines whether time of dosing impacts on the biomarkers.C57Bl6/Jax mice were fed 60% kcal...

ea0021p187 | Diabetes and metabolism | SFEBES2009

Down-regulation of adipose 11βHSD1 mediates the insulin sensitising effects of salicylate in obesity

Nixon Mark , Livingstone Dawn , Andrew Ruth , Walker Brian

Anti-inflammatory salicylates improve insulin sensitivity, however the mechanism remains unclear. We have observed down-regulation of the glucocorticoid regenerating enzyme 11β-hydroxysteroid dehydrogenase 1 (11βHSD1) by salicylates in cultured adipocytes and in human adipose tissue after oral salsalate therapy, consistent with known transcriptional regulation of 11βHSD1 by pro-inflammatory cytokines. Since inhibition of 11βHSD1 improves insulin sensitivity...

ea0021p212 | Endocrine tumours and neoplasia | SFEBES2009

Routine central compartment lymph node dissection for papillary thyroid cancer has minimal impact on early postoperative parameters

Parameswaran Rajeev , Stechman Michael , Weaver Andrew , Sadler Gregory , Mihai Radu

Background: Arguably patients undergoing total thyroidectomy for papillary thyroid cancers (PTC) are more likely to have negative radioactive iodine uptake and low/undetectable thyroglobulin levels if the central compartment lymph node dissection (CCLND) is performed routinely irrespective of the macroscopic appearance of the LN. The aim of this study was to determine whether routine CCLND leads to more favourable outcome in the first year after treatment for well-differentiat...

ea0021p225.1 | Endocrine tumours and neoplasia | SFEBES2009

The microRNA let-7a is downregulated in pituitary tumours from a multiple endocrine neoplasia type-1 mouse model

Dyar Rebecca , Newey Paul , Nesbit Andrew , Walls Gerard , Thakker Rajesh

MicroRNAs are highly conserved non-coding RNAs that regulate diverse cellular processes. Altered microRNA expression is observed in many human cancers and microRNAs may have tumour suppressor or oncogenic properties. One group of putative tumour suppressor microRNAs is the let-7 family whose expression is reduced in several human tumours, and which inhibit the expression of several oncogenes including HMGA2 and K-Ras. Let-7 expression have also been observed to b...

ea0021p227 | Growth and development | SFEBES2009

Altered responses to GH and IGF1 in children born small for gestational age without post-natal catch up growth

Butcher Imogen , Whatmore Andrew , Murray Philip , Westwood Melissa , Clayton Peter

Background: Infants born small for gestational age (SGA) usually show catch up growth within the first few years of life. However in the UK ~1500 SGA children each year remain small, with no clear endocrine cause with rare genetic syndromes accounting for only a minority of cases. In order to define growth factor activation in these children we have initiated an assessment of cell growth and signalling in response to GH and IGF1 in fibroblast cell lines....

ea0021p257 | Pituitary | SFEBES2009

Carcinomatous change in a craniopharyngioma: a case report

Akhtar Simeen , Golash Aprajay , Gunawardena Windsor , Hindley Andrew , Howell Simon

Introduction: Craniopharyngiomas are usually benign intracranial tumours which can sometimes be locally aggressive. Malignant transformation is extremely rare and has a poor prognosis. We report a case of a patient who developed carcinomatous changes in a craniopharyngioma which was first excised almost 55 years ago.Case report: Mr AM was diagnosed with a craniopharyngioma at the age of 5 years. He underwent surgery in 1952 but was lost to follow up and ...